Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma

BACKGROUND: ChromograninA in prostate carcinoma (PC) indicate NE differentiation. This tumour is more aggressive and resistant to hormone therapy. PATIENTS AND METHODS: We analyzed the incidence of pre-operative ChromograninA serum levels in non metastatic PC patients. Serum PSA and ChromograninA we...

Descripción completa

Detalles Bibliográficos
Autores principales: Appetecchia, Marialuisa, Meçule, Aurela, Pasimeni, Giuseppe, Iannucci, Concetta V, De Carli, Piero, Baldelli, Roberto, Barnabei, Agnese, Cigliana, Giovanni, Sperduti, Isabella, Gallucci, Michele
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018395/
https://www.ncbi.nlm.nih.gov/pubmed/21162758
http://dx.doi.org/10.1186/1756-9966-29-166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018395/
https://www.ncbi.nlm.nih.gov/pubmed/21162758
http://dx.doi.org/10.1186/1756-9966-29-166

Ejemplares similares